BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33996260)

  • 1. Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer.
    Li J; Pan T; Chen L; Wang Q; Chang Z; Zhou W; Li X; Xu G; Li X; Li Y; Zhang Y
    Mol Ther Nucleic Acids; 2021 Jun; 24():792-806. PubMed ID: 33996260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.
    Li Y; McGrail DJ; Xu J; Li J; Liu NN; Sun M; Lin R; Pancsa R; Zhang J; Lee JS; Wang H; Mills GB; Li X; Yi S; Sahni N
    Hepatology; 2019 Aug; 70(2):532-546. PubMed ID: 30153342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive expression landscape of RNA-binding proteins (RBPs) across 16 human cancer types.
    Zhang B; Babu KR; Lim CY; Kwok ZH; Li J; Zhou S; Yang H; Tay Y
    RNA Biol; 2020 Feb; 17(2):211-226. PubMed ID: 31607220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human protein-RNA interaction network is highly stable across mammals.
    Ramakrishnan A; Janga SC
    BMC Genomics; 2019 Dec; 20(Suppl 12):1004. PubMed ID: 31888461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulator-Dependent RBPs Changes Alternative Splicing Outcomes in Kidney Cancer.
    Wang Y; Chen SX; Rao X; Liu Y
    Front Genet; 2020; 11():265. PubMed ID: 32273884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer.
    Zhou W; Jie Q; Pan T; Shi J; Jiang T; Zhang Y; Ding N; Xu J; Ma Y; Li Y
    Commun Biol; 2023 Jan; 6(1):82. PubMed ID: 36681772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns by Altering Their Interaction Landscape with RNA-Binding Proteins.
    Porto FW; Daulatabad SV; Janga SC
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31390792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification and functional analysis of dysregulated alternative splicing profiles in sepsis.
    Tuerdimaimaiti D; Abuduaini B; Kang S; Jiao J; Li M; Madeniyati W; Tuerdi B; Aili G; Tuerhong R; Kulaxi A
    J Inflamm (Lond); 2023 Sep; 20(1):31. PubMed ID: 37749550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases.
    He Q; Li Z; Lei X; Zou Q; Yu H; Ding Y; Xu G; Zhu W
    Cancer Cell Int; 2021 Jun; 21(1):325. PubMed ID: 34193169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of alternative splicing and RNA-binding proteins involved in myocardial ischemia-reperfusion injury.
    Feng L; Guo M; Jin C
    Genome; 2023 Oct; 66(10):261-268. PubMed ID: 37466303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
    Saha S; Murmu KC; Biswas M; Chakraborty S; Basu J; Madhulika S; Kolapalli SP; Chauhan S; Sengupta A; Prasad P
    Front Oncol; 2019; 9():692. PubMed ID: 31448224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression.
    Wang J; Qi J; Hou X
    Front Genet; 2019; 10():1394. PubMed ID: 32047515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome-wide analysis reveals the coregulation of RNA-binding proteins and alternative splicing genes in the development of atherosclerosis.
    Wang R; Xu J; Tang Y; Wang Y; Zhao J; Ding L; Peng Y; Zhang Z
    Sci Rep; 2023 Jan; 13(1):1764. PubMed ID: 36720950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
    Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives.
    Kang D; Lee Y; Lee JS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis.
    Mei C; Song PY; Zhang W; Zhou HH; Li X; Liu ZQ
    Front Oncol; 2020; 10():568469. PubMed ID: 33178596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of RNA and RNA-binding protein network in cancer cells.
    Kim MY; Hur J; Jeong S
    BMB Rep; 2009 Mar; 42(3):125-30. PubMed ID: 19335997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities.
    Wang S; Sun H; Chen G; Wu C; Sun B; Lin J; Lin D; Zeng D; Lin B; Huang G; Lu X; Lin H; Liang Y
    Crit Rev Oncol Hematol; 2024 Mar; 195():104271. PubMed ID: 38272151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBPvsMIR: A Computational Pipeline to Identify Competing miRNAs and RNA-Binding Protein Pairs Regulating the Shared Transcripts.
    Zhao X; Chen D; Cai Y; Zhang F; Xu J
    Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30131454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.